Figures & data
Table 1. Agency for toxic substances and disease registry (ATSDR) criteria for appropriateness of medical monitoring programs as a public health activity.
Figure 1. U.S. Preventive Services Task Force Grades for clinical preventive services. Adapted from http://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions.
![Figure 1. U.S. Preventive Services Task Force Grades for clinical preventive services. Adapted from http://www.uspreventiveservicestaskforce.org/Page/Name/grade-definitions.](/cms/asset/34d1bbfa-b653-46ec-9fff-8e5dba91f79e/ictx_a_1334913_f0001_b.jpg)
Figure 2. U.S. Preventive Services Task Force analytic framework for evaluation of a clinical preventive service. Adapted from: United States Preventive Services Task Force, Procedure Manual, Agency for Healthcare Research and Quality, 2008.
![Figure 2. U.S. Preventive Services Task Force analytic framework for evaluation of a clinical preventive service. Adapted from: United States Preventive Services Task Force, Procedure Manual, Agency for Healthcare Research and Quality, 2008.](/cms/asset/47fc1cec-9d96-4db3-963a-12add0477a30/ictx_a_1334913_f0002_b.jpg)
Table 2. Initial monitoring protocols for the C-8 medical monitoring program.
Table 3. Estimated total cancer cases attributable to Fernald-related radiation exposure compared with background cancer cases.